Tocilizumab: from the rheumatology practice to the fight against COVID-19, a virus infection with multiple faces-Reference-Cited by-同舟云学术

Tocilizumab: from the rheumatology practice to the fight against COVID-19, a virus infection with multiple faces

Published:2020-06-04 Issue:7 Volume:20 Page:717-723
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

González-Gay Miguel A.¹²³,Mayo José⁴,Castañeda Santos⁵,Cifrián José M.⁶,Hernández-Rodríguez José⁷

Affiliation:

1. Division of Rheumatology and Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain

2. University of Cantabria, Santander, Spain

3. Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

4. Infectious Diseases Unit, Galdakao-Usansolo Hospital, Galdakao, Bizkaia, Spain

5. Rheumatology Division, Hospital de La Princesa, IIS-Princesa, Cátedra UAM-Roche, EPID Future, Universidad Autónoma de Madrid (UAM), Madrid, Spain

6. Division of Pneumology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain

7. Vasculitis Research Unit and Clinical Unit of Autoinflammatory Diseases, Department of Autoimmune Diseases, Hospital Clínic of Barcelona, University of Barcelona, Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain

Funder

not funded

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2020.1770222

Reference28 articles.

1. Effective treatment of severe COVID-19 patients with tocilizumab

2. Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy

3. The role of Interleukin 6 in the pathophysiology of rheumatoid arthritis